Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL, Bryant J, Dimitrov NV, Abramson N, Atkins JN, Shibata H, Deschenes L, Margolese RG.
Fisher B, et al.
J Natl Cancer Inst. 1997 Nov 19;89(22):1673-82. doi: 10.1093/jnci/89.22.1673.
J Natl Cancer Inst. 1997.
PMID: 9390536
Clinical Trial.